Harbour Antibodies Licenses H2L2 Mice to Pfizer Inc.

Published: Jul 24, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROTTERDAM, the Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour Antibodies, the creator of transgenic mice to aid in the development of new human therapeutic antibodies, announced today that it has licensed its H2L2 mice, which can generate human monoclonal antibodies, to Pfizer Inc.

Help employers find you! Check out all the jobs and post your resume.

Back to news